Literature DB >> 28941189

Efficacy of a Work Disability Prevention Program for People with Rheumatic and Musculoskeletal Conditions: A Single-Blind Parallel-Arm Randomized Controlled Trial.

Julie J Keysor1, Michael P LaValley2, Carrie Brown3, David T Felson4, Rawan A AlHeresh5, Molly W Vaughan6, Robert Yood7, John I Reed7, Saralynn J Allaire1.   

Abstract

OBJECTIVE: Work disability rates are high among people with rheumatic and musculoskeletal conditions. Effective disability preventive programs are needed. We examined the efficacy of a modified vocational rehabilitation approach delivered by trained occupational therapists and physical therapists on work limitation and work loss over 2 years among people with rheumatic and musculoskeletal conditions.
METHODS: Eligibility criteria for this single-blind, parallel-arm randomized trial included ages 21-65 years, 15 or more hours/week employment, a self-reported doctor-diagnosed rheumatic or musculoskeletal condition, and concern about staying employed. The intervention consisted of a 1.5-hour meeting, an action plan, written materials on employment supports, and telephone calls at 3 weeks and 3 months. Control group participants received the written materials. The primary outcome was the Work Limitations Questionnaire (WLQ) output job demand subscale. The secondary outcome was work loss. Intent-to-treat analyses were performed.
RESULTS: Between October 2011 and January 2014, 652 individuals were assessed for eligibility. A total of 287 participants were randomized: 143 intervention and 144 control participants. In total, 264 participants (92%) completed 2-year data collection. There was no difference in the mean ± SD WLQ change scores from baseline to 2-year followup (-8.6 ± 1.9 intervention versus -8.3 ± 2.2 control; P = 0.93). Of the 36 participants who experienced permanent work loss at 2 years, 11 (8%) were intervention participants and 25 (18%) control participants (P = 0.03).
CONCLUSION: The intervention did not have an effect on work limitations but reduced work loss. The intervention can be delivered by trained rehabilitation therapists.
© 2017, American College of Rheumatology.

Entities:  

Mesh:

Year:  2018        PMID: 28941189      PMCID: PMC6374024          DOI: 10.1002/acr.23423

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  27 in total

1.  The Work Limitations Questionnaire's validity and reliability among patients with osteoarthritis.

Authors:  Debra Lerner; John I Reed; Elena Massarotti; Lisa M Wester; Thomas A Burke
Journal:  J Clin Epidemiol       Date:  2002-02       Impact factor: 6.437

2.  Combined impact of concomitant arthritis and back problems on health status: results from a nationally representative health survey.

Authors:  Dimitri Bollegala; Anthony V Perruccio; Elizabeth M Badley
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

3.  The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study.

Authors:  E M Barrett; D G Scott; N J Wiles; D P Symmons
Journal:  Rheumatology (Oxford)       Date:  2000-12       Impact factor: 7.580

Review 4.  Non-pharmacological interventions for preventing job loss in workers with inflammatory arthritis.

Authors:  Jan L Hoving; Diane Lacaille; Donna M Urquhart; Timo J Hannu; Judith K Sluiter; Monique H W Frings-Dresen
Journal:  Cochrane Database Syst Rev       Date:  2014-11-06

5.  Reducing work disability associated with rheumatoid arthritis: identification of additional risk factors and persons likely to benefit from intervention.

Authors:  S H Allaire; J J Anderson; R F Meenan
Journal:  Arthritis Care Res       Date:  1996-10

6.  Work limitations among working persons with rheumatoid arthritis: results, reliability, and validity of the work limitations questionnaire in 836 patients.

Authors:  Nancy Walker; Kaleb Michaud; Frederick Wolfe
Journal:  J Rheumatol       Date:  2005-06       Impact factor: 4.666

7.  The Work Limitations Questionnaire.

Authors:  D Lerner; B C Amick; W H Rogers; S Malspeis; K Bungay; D Cynn
Journal:  Med Care       Date:  2001-01       Impact factor: 2.983

8.  Work performance of employees with depression: the impact of work stressors.

Authors:  Debra Lerner; David A Adler; William H Rogers; Hong Chang; Leueen Lapitsky; Thomas McLaughlin; John Reed
Journal:  Am J Health Promot       Date:  2010 Jan-Feb

9.  A proof-of-concept study of the "Employment and Arthritis: Making It Work" program.

Authors:  Diane Lacaille; Margaret A White; Pam A Rogers; Catherine L Backman; Monique A M Gignac; John M Esdaile
Journal:  Arthritis Rheum       Date:  2008-11-15

10.  One Year Effects of a Workplace Integrated Care Intervention for Workers with Rheumatoid Arthritis: Results of a Randomized Controlled Trial.

Authors:  M van Vilsteren; C R L Boot; J W R Twisk; R Steenbeek; A E Voskuyl; D van Schaardenburg; J R Anema
Journal:  J Occup Rehabil       Date:  2017-03
View more
  4 in total

1.  Pain rates in general population for the period 1991-2015 and 10-years prediction: results from a multi-continent age-period-cohort analysis.

Authors:  Davide Guido; Matilde Leonardi; Blanca Mellor-Marsá; Maria V Moneta; Albert Sanchez-Niubo; Stefanos Tyrovolas; Iago Giné-Vázquez; Josep M Haro; Somnath Chatterji; Martin Bobak; Jose L Ayuso-Mateos; Holger Arndt; Ilona Koupil; Jerome Bickenbach; Seppo Koskinen; Beata Tobiasz-Adamczyk; Demosthenes Panagiotakos; Alberto Raggi
Journal:  J Headache Pain       Date:  2020-05-13       Impact factor: 7.277

2.  Recruitment cost and outcomes for an arthritis work disability prevention randomized clinical trial: The Work It study.

Authors:  Rawan AlHeresh; Molly W Vaughan; Inbar Hanouna Brenner; Julie Keysor
Journal:  Contemp Clin Trials Commun       Date:  2021-11-12

3.  The effect on work presenteeism of job retention vocational rehabilitation compared to a written self-help work advice pack for employed people with inflammatory arthritis: protocol for a multi-centre randomised controlled trial (the WORKWELL trial).

Authors:  Alison Hammond; Chris Sutton; Sarah Cotterill; Sarah Woodbridge; Rachel O'Brien; Kate Radford; Denise Forshaw; Suzanne Verstappen; Cheryl Jones; Antonia Marsden; Martin Eden; Yeliz Prior; June Culley; Paula Holland; Karen Walker-Bone; Yvonne Hough; Terence W O'Neill; Angela Ching; Jennifer Parker
Journal:  BMC Musculoskelet Disord       Date:  2020-09-10       Impact factor: 2.362

4.  Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis.

Authors:  James M Gwinnutt; Sarah Leggett; Mark Lunt; Anne Barton; Kimme L Hyrich; Karen Walker-Bone; Suzanne M M Verstappen
Journal:  Rheumatology (Oxford)       Date:  2020-10-01       Impact factor: 7.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.